James Huang

Bio

Mr Huang has extensive operating and business development experience through 20 years of experience in the pharmaceutical industry. He joined Vivo from Anesiva, where he served as president and previously as senior vice president of business development and commercial operations. Prior to Anesiva, he was VP Business Development and Commercial Operations at Tularik Inc prior to its acquisition by Amgen. Mr Huang was also a product director for diabetes at SmithKline Beecham plc (now GlaxoSmithKline), and also held various positions in product development, business development, sales and marketing, and research and development at SmithKline Beecham, Bristol-Myers Squibb, and Alza (now a Johnson & Johnson company). Mr Huang received an MBA from Stanford Graduate School of Business and earned a BS degree in Chemical Engineering at the University of California, Berkeley.